Novocuff
PrivateLast Round
Series A
Jul 17, 2024
Total Funding Raised
$26.3M
Company Overview
Novocuff operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a Series A round in July 2024.
Novocuff is a medical device company that creates innovative solutions to prevent preterm birth, including a minimally invasive device designed to stabilize the cervix and extend pregnancy duration for both singleton and multiple gestation pregnancies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novocuff Comparables
Compare Novocuff with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PregnanTech | 93% | |
| Cx Therapeutics, Inc. | 80% | |
| Dr. Arabin GmbH & Co. KG | 74% |
For institutional investors. Book with your work email.
Novocuff Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 17, 2024 | ||||
| Grant | Aug 10, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novocuff Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| March of Dimes | Series A |
| NIH RADx | Grant |
| Avestria Ventures | Series A |
| RH Capital | Series A |
Novocuff Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novocuff's valuation, stock price, and market status.
Is Novocuff a public or private company?
Novocuff is a private company.
What is the current stock price of Novocuff?
Novocuff is a private company, so its shares have no public market price. Caplight tracks Novocuff's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novocuff worth (valuation)?
Valuation information for Novocuff is not publicly available.
Can I buy Novocuff stock?
Novocuff shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novocuff's last funding round?
Novocuff's most recent funding round was Series A on July 17, 2024.
Who are the main investors in Novocuff?
Key investors in Novocuff include March of Dimes, NIH RADx, Avestria Ventures, RH Capital.
Will Novocuff IPO soon?
No public IPO plans have been announced for Novocuff.
How can I track Novocuff secondary market activity?
Caplight tracks bids, offers, and trades in Novocuff's shares on secondary markets.